Page last updated: 2024-08-26

mafosfamide and Leukemia, Myeloid

mafosfamide has been researched along with Leukemia, Myeloid in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hassan, HT1
Rowley, SD1
Buschfort, C; Müller, MR; Rajewsky, MF; Seeber, S; Seiler, F; Thomale, J1
Bruecher, J; Claudé, R; Hoelzer, D; Martin, H1
Fouillard, L; Gorin, NC; Isnard, F; Jouet, JP; Laporte, JP; Lesage, S; Michailov, G; Najman, A; Noel-Walter, MP1
Bouchet, S; Douay, L; Giarratana, MC; Gorin, NC; Harnois, C; Laporte, JP; Lopez, M; Yao, M1
Bader, P; Brugger, W; Grünebach, F; Kanz, L; Scheding, S; Stilz, R; Vogel, W1
Bonati, A; Carlo-Stella, C; Mangoni, L; Rizzoli, V1

Reviews

1 review(s) available for mafosfamide and Leukemia, Myeloid

ArticleYear
Hematopoietic growth factors: in vitro and in vivo studies in bone marrow transplantation.
    International journal of cell cloning, 1990, Volume: 8 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Colony-Stimulating Factors; Cyclophosphamide; Hematopoiesis; Humans; In Vitro Techniques; Leukemia, Myeloid; Neutropenia; Transplantation, Autologous

1990

Other Studies

7 other study(ies) available for mafosfamide and Leukemia, Myeloid

ArticleYear
Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells.
    Medical oncology (Northwood, London, England), 1994, Volume: 11, Issue:3-4

    Topics: Adjuvants, Immunologic; Antineoplastic Agents; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Synergism; Humans; Immunotherapy, Adoptive; Interleukin-2; Leukemia, Myeloid; T-Lymphocytes, Regulatory; Tumor Cells, Cultured

1994
Bone marrow purging, 4-hydroperoxycyclophosphamide, and the FDA.
    Journal of hematotherapy, 1993,Fall, Volume: 2, Issue:3

    Topics: Acute Disease; Bone Marrow; Bone Marrow Purging; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Industry; Drug Utilization; Ethics, Medical; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Neoplasm, Residual; Treatment Outcome; United States; United States Food and Drug Administration

1993
Capacity of individual chronic lymphatic leukemia lymphocytes and leukemic blast cells for repair of O6-ethylguanine in DNA: relation to chemosensitivity in vitro and treatment outcome.
    Cancer research, 1994, Aug-15, Volume: 54, Issue:16

    Topics: Acute Disease; Carmustine; Cyclophosphamide; Cytarabine; DNA Repair; Doxorubicin; Drug Resistance; Ethylnitrosourea; Glutathione; Guanine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Lymphocytes; Treatment Outcome

1994
Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Bone marrow transplantation, 1993, Volume: 12, Issue:5

    Topics: Adult; Antineoplastic Agents; Bone Marrow; Bone Marrow Purging; Cryopreservation; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Female; Granulocytes; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Macrophages; Male; Middle Aged; Remission Induction

1993
Autologous bone marrow transplantation is feasible in patients with a prior history of invasive pulmonary aspergillosis.
    Bone marrow transplantation, 1996, Volume: 17, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bone Marrow Purging; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Feasibility Studies; Female; Humans; Itraconazole; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Premedication; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous

1996
Quantitative and qualitative alterations of long-term culture-initiating cells in patients with acute leukaemia in complete remission.
    British journal of haematology, 1998, Volume: 103, Issue:1

    Topics: Acute Disease; Antineoplastic Agents; Bone Marrow Purging; Cyclophosphamide; Hematopoiesis; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Transplantation, Autologous

1998
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Journal of hematotherapy & stem cell research, 2001, Volume: 10, Issue:6

    Topics: Acute Disease; Antigens, CD34; Antineoplastic Agents; Blood Cells; Bone Marrow Purging; Cell Division; Coculture Techniques; Cyclophosphamide; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid; Neoplastic Stem Cells

2001